Preneoplastic and preinvasive lesions

Diagnostic Pulmonary Pathology, Second Edition

Volumn , Issue , 2008, Pages 519-537

  Kerr, Keith M ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79251625067     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (55)

1. Travis WD, Brambilla E, Muller-Hermelink HK, et al., eds. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart. Lyon: IARC Press, 2004.
2. Kerr KM, Fraire AE. Preinvasive diseases of the lung. In: Tomashefski J, Farver C, Cagle P, Fraire A, eds. Dail and Hammer’s Pulmonary Pathology, Vol 2, 3rd ed. New York: Springer, 2008: pp.158-215.
3. Kerr KM, Noguchi M. Pathology of screen-detected lesions. In: Hirsch FR, Bunn PA Jr., Kato H, et al., eds. IASLC Textbook on Prevention and Early Detection of Lung Cancer. London, UK: Martin Dunitz Publisher, 2005:245-267.
4. Franklin WA, Wistuba II, Geisinger K, et al. Squamous dysplasia and carcinoma in situ. In: Travis WD, Brambilla E, Muller-Hermelink HK, et al., eds. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart. Lyon: IARC Press, 2004:68-72.
5. Lam S, MacAulay C, LeRiche JC, et al. Detection and localization of early lung cancer by fluorescence bronchoscopy. Cancer 2000; 89:2468-2473.
6. Lam S, Kennedy T, Unger M, et al. Localization of bronchial intraepithelial lesions by fluorescence bronchoscopy. Chest 1998; 113:696-702.
7. Lam S, LeRiche JC, Zheng Y, et al. Sex-related differences in bronchial epithelial changes associated with tobacco smoking. J Natl Cancer Inst 1999;91:691-696.
8. Keith RL, Miller YE, Gemmill RM, et al. Angiogenic squamous dysplasia in bronchi of individuals at high risk for lung cancer. Clin Cancer Res 2000; 6:1616-1625.
9. Kerr KM. Morphology and genetics of preinvasive pulmonary disease. Curr Diag Pathol 2004; 10:259-268.
10. Thun MJ, Lally CA, Flannery JT, et al. Cigarette smoking and changes in the histopathology of lung cancer. J Natl Cancer Inst 1997; 89:1580-1586.
11. Strauss GM, Jemal A, McKenna MB, et al. The epidemic of smoking-related adenocarcinoma of the lung: the role of the tobacco industry and filtered and low-tar cigarettes. J Thorac Oncol 2007; 2(suppl 4):S305.
12. Wang GF, Lai MD, Yang RR, et al. Histological types and significance of bronchial epithelial dysplasia. Mod Pathol 2006; 19:429-437.
13. Spencer H, Dail DH, Arneaud J. Non-invasive bronchial epithelial papillary tumors. Cancer 1980; 45:1486-1497.
14. Hammar SP, Brambilla C, Pugatch R, et al. Squamous cell carcinoma. In: Travis WD, Brambilla E, Muller-Hermelink HK, et al., eds. World Health Organisation Classification of Tumours. Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart. Lyon: IARC Press, 2004:26-30.
15. Banerjee AK, Rabbitts PH, George J. Lung cancer 3: fluorescence bronchoscopy: clinical dilemmas and research opportunities. Thorax 2003; 58:266-271.
16. Venmans BJ, van Boxem TJ, Smit EF, et al. Outcome of bronchial carcinoma in situ. Chest 2000; 117:1572-1576.
17. Bota S, Auliac J-B, Paris C, et al. Follow-up of bronchial precancerous lesions and carcinoma in situ using fluorescence endoscopy. Am J Crit Care 2001; 164:1688-1693.
18. Tan KK, Kennedy MM, Kerr KM, et al. Patient survival and bronchial resection line status in primary lung carcinoma. Thorax 1995; 50:437P.
19. Pasic A, Gr�?nberg K, Mooi W, et al. The natural history of carcinoma in situ involving bronchial resection margins. Lung Cancer 2005; 49(suppl 2):S57.
20. Aubert A, Moro-Sibilot D, Diab S, et al. Prognostic significance of carcinoma in situ in the vicinity of non small cell resected lung cancer in stage I to IIIA. Lung Cancer 2005; 49(suppl 2):S57.
21. Jeanmart M, Lantuejoul S, Fievet F, et al. Value of immunohistochemical markers in preinvasive bronchial lesions in risk assessment of lung cancer. Clin Cancer Res 2003; 9:2195-2203.
22. Ponticiello A, Barra E, Giani U, et al. P53 immunohistochemistry can identify bronchial dys-plastic lesions proceeding to lung cancer: a prospective study. Eur Respir J 2000; 15:547-552.
23. Sozzi G, Oggionni M, Alasio L, et al. Molecular changes track recurrence and progression of bronchial precancerous lesions. Lung Cancer 2002; 37:267-270.
24. Brambilla E, Gazzeri S, Lantuejoul S, et al. p53 mutant immunophenotype and deregulation of p53 transcription pathway (bcl2, bax and waf1) in precursor bronchial lesions of lung cancer. Clin Cancer Res 1998; 4:1609-1618.
25. Brambilla E, Gazzeri S, Moro D, et al. Alterations of Rb pathway (Rb-p16INK4-cyclin D1) in preinvasive bronchial lesions. Clin Cancer Res 1999; 5:243-250.
26. Nicholson AG, Perry LJ, Cury PM, et al. Reproducibility of the WHO/IASLC grading system for pre-invasive squamous lesions of the bronchus: a study of inter-observer and intra-observer variation. Histopathology 2001; 38:202-208.
27. Venmans BJ, van Boxem TJ, Smit EF, et al. Outcome of bronchial carcinoma in situ. Chest 2000; 117:1572-1576.
28. Kerr KM, Fraire AE, Pugatch B, et al. Atypical adenomatous hyperplasia. In: Travis WD, Brambilla E, Muller-Hermelink HK, et al., eds. World Health Organisation Classification of Tumours. Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart. Lyon: IARC Press, 2004:73-75.
29. Weng SY, Tsuchiya E, Kasuga T, et al. Incidence of atypical bronchioloalveolar cell hyperplasia of the lung: relation to histological subtypes of lung cancer. Virchows Arch A Pathol Anat Histopathol 1992; 420:463-471.
30. Koga T, Hashimoto S, Sugio K, et al. Lung adenocarcinoma with bronchioloalveolar carcinoma component is frequently associated with foci of high-grade atypical adenomatous hyperplasia. Am J Clin Pathol 2002; 117:464-470.
31. Nakahara R, Yokose T, Nagai K, et al. Atypical adenomatous hyperplasia of the lung: a clinicopathological study of 118 cases including cases with multiple atypical adenomatous hyperplasia. Thorax 2001; 56:302-305.
32. Miller RR. Bronchioloalveolar cell adenomas. Am J Surg Pathol 1990; 14:904-912.
33. Chapman AD, Kerr KM. The association between atypical adenomatous hyperplasia and primary lung cancer. Br J Cancer 2000; 83:632-636.
34. Sterner DJ, Masuko M, Roggli VL, et al. Prevalence of pulmonary atypical alveolar cell hyperplasia in an autopsy population: a study of 100 cases. Mod Pathol 1997; 10:469-473.
35. Yokose T, Doi M, Tanno K, et al. Atypical adenomatous hyperplasia of the lung in autopsy cases. Lung Cancer 2001; 33:155-161.
36. Anami Y, Matsuno Y, Yamada T, et al. A case of double primary adenocarcinoma of the lung with multiple atypical adenomatous hyperplasia. Pathol Int 1998; 48:634-640.
37. Kitamura H, Kameda Y, Ito T, et al. Cytodifferentiation of atypical adenomatous hyperplasia and bronchioloalveolar lung carcinoma: immunohistochemical and ultrastructural studies. Virchows Arch 1997; 431:415-424.
38. Ullman R, Bongiovanni M, Halbwedl I, et al. Bronchiolar columnar cell dysplasia - genetic analysis of a novel preneoplastic lesion of peripheral lung. Virchows Arch 2003; 442:429-436.
39. Muir TE, Leslie KO, Popper H, et al. Micronodular pneumocyte hyperplasia. Am J Surg Pathol 1998; 22:465-472.
40. Lantuejoul S, Ferretti G, Negoescu A, et al. Multifocal alveolar hyperplasia associated with lymphangioleiomyomatosis in tuberous sclerosis. Histopathol 1997; 30:570-575.
41. Colby TV, Noguchi M, Henschke C, et al. Adenocarcinoma. In: Travis WD, Brambilla E, Muller-Hermelink HK, et al., eds. World Health Organisation Classification of Tumours. Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart. Lyon: IARC Press, 2004:35-44.
42. Noguchi M, Morokawa A, Kawasaki M, et al. Small adenocarcinoma of the lung. Histologic characteristics and prognosis. Cancer 1995; 75:2844-2852.
43. Travis WD, Garg K, Franklin WA, et al. Evolving concepts in the pathology and CT imaging of lung adenocarcinoma and bronchioloalveolar carcinoma. J Clin Oncol 2005; 23:3279-3287.
44. Travis WD, Garg K, Franklin WA, et al. Bronchioloalveolar carcinoma and lung adenocarcinoma: the clinical importance and research relevance of the 2004 WHO Pathologic criteria. J Thorac Oncol 2006; 1(9):S13-S19.
45. Flieder DB, Vasquez M, Carter D, et al. Pathologic findings of lung tumors diagnosed on baseline CT screening. Am J Surg Pathol 2006; 30:606-613.
46. Sheffield EA, Addis BJ, Corrin B, et al. Epithelial hyperplasia and malignant change in congenital lung cysts. J Clin Pathol 1987; 40:612-614.
47. Dail DH, Cagle PT, Marchevsky AM, et al. Metastases to the lung. In: Travis WD, Brambilla E, Muller-Hermelink HK, et al., eds. World Health Organisation Classification of Tumours. Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart. Lyon: IARC Press, 2004:122-124.
48. Kerr KM, Devereux G, Chapman AD, et al. Is survival after surgical resection of lung cancer influenced by the presence of atypical adenomatous hyperplasia (AAH)? J Thorac Oncol 2007; 2 (suppl 4):S401.
49. Nomori H, Ohtsuka T, Naruke T, et al. Differentiating between atypical adenomatous hyperplasia and bronchioloalveolar carcinoma using the computed tomography number histogram. Ann Thorac Surg 2003; 76:867-871.
50. Gosney JR, Travis WD. Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia. In: Travis WD, Brambilla E, Muller-Hermelink HK, et al., eds. World Health Organisation Classification of Tumours. Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart. Lyon: IARC Press, 2004:76-77.
51. Colby TV, Koss MN, Travis WD. Carcinoid and other neuroendocrine tumours. In: Tumours of the Lower Respiratory Tract. Washington: AFIP, 1994:290-294.
52. Aguayo SM, Miller YE, Waldron JA, et al. Idiopathic diffuse hyperplasia of pulmonary neuroendocrine cells and airway disease. N Engl J Med 1992; 327:1285-1288.
53. Davies SJ, Gosney JR, Hansell DM, et al. Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia: an under-recognised spectrum of disease. Thorax 2007; 62:248-252.
54. Churg A, Warnock ML. Pulmonary tumourlet. A form of peripheral carcinoid. Cancer 1976; 37:1469-1477.
55. Miller RR, Muller NL. Neuroendocrine cell hyperplasia and obliterative bronchiolitis in patients with peripheral carcinoid tumours. Am J Surg Pathol 1995; 19:653-658.